ALNY vs DEO · P/E 76, rev $1.29B vs P/E 16, $55.86B cap
Alnylam Pharmaceuticals Inc (ALNY) versus Diageo PLC ADR (DEO) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
DEO does not have a complete income-statement cache yet.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. DEO currently screens at market cap $55.86B and trailing P/E 15.6.
Not investment advice. Open the ALNY and DEO stock pages for the full models.
Not investment advice.